[1] |
REUBEN A, TILLMAN H, FONTANA RJ, et al. Outcomes in adults with acute liver failure between 1998 and 2013: An observational cohort study[J]. Ann Intern Med, 2016, 164(11): 724-732. DOI: 10.7326/M15-2211.
|
[2] |
REUBEN A, KOCH DG, LEE WM. Drug-induced acute liver failure: Results of a U.S. multicenter, prospective study[J]. Hepatology, 2010, 52(6): 2065-2076. DOI: 10.1002/hep.23937.
|
[3] |
CRAIG DG, BATES CM, DAVIDSON JS, et al. Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity[J]. Br J Clin Pharmacol, 2011, 71(2): 273-282. DOI: 10.1111/j.1365-2125.2010.03819.x.
|
[4] |
SHEN T, LIU Y, SHANG J, et al. Incidence and etiology of drug-induced liver injury in mainland China[J]. Gastroenterology, 2019, 156(8): 2230-2241. e11. DOI: 10.1053/j.gastro.2019.02.002.
|
[5] |
SGRO C, CLINARD F, OUAZIR K, et al. Incidence of drug-induced hepatic injuries: A French population-based study[J]. Hepatology, 2002, 36(2): 451-455. DOI: 10.1053/jhep.2002.34857.
|
[6] |
HILLMAN L, GOTTFRIED M, WHITSETT M, et al. Clinical features and outcomes of complementary and alternative medicine induced acute liver failure and injury[J]. Am J Gastroenterol, 2016, 111(7): 958-965. DOI: 10.1038/ajg.2016.114.
|
[7] |
MURRAY KF, HADZIC N, WIRTH S, et al. Drug-related hepatotoxicity and acute liver failure[J]. J Pediatr Gastroenterol Nutr, 2008, 47(4): 395-405. DOI: 10.1097/MPG.0b013e3181709464.
|
[8] |
TREY C, DAVIDSON CS. The management of fulminant hepatic failure[J]. Prog Liver Dis, 1970, 3: 282-298.
|
[9] |
TANDON BN, BERNAUAU J, O'Grady J, et al. Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure[J]. J Gastroenterol Hepatol, 1999, 14(5): 403-404. DOI: 10.1046/j.1440-1746.1999.01905.x.
|
[10] |
CRAIG DG, ZAFAR S, REID TW, et al. The sequential organ failure assessment (SOFA) score is an effective triage marker following staggered paracetamol (acetaminophen) overdose[J]. Aliment Pharmacol Ther, 2012, 35(12): 1408-1415. DOI: 10.1111/j.1365-2036.2012.05102.x.
|
[11] |
BERNAL W, AUZINGER G, DHAWAN A, et al. Acute liver failure[J]. Lancet, 2010, 376(9736): 190-201. DOI: 10.1016/S0140-6736(10)60274-7.
|
[12] |
REDDY KR, ELLERBE C, SCHILSKY M, et al. Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States[J]. Liver Transpl, 2016, 22(4): 505-515. DOI: 10.1002/lt.24347.
|
[13] |
ANDRADE RJ, LUCENA MI, FERNÁNDEZ MC, et al. Drug-induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10-year period[J]. Gastroenterology, 2005, 129(2): 512-521. DOI: 10.1016/j.gastro.2005.05.006.
|
[14] |
BERNUAU J, BENHAMOU JP. Classifying acute liver failure[J]. Lancet, 1993, 342(8866): 252-253. DOI: 10.1016/0140-6736(93)91809-z.
|
[15] |
RIORDAN SM, WILLIAMS R. Liver disease due to illicit substance use[J]. Addict Biol, 1998, 3(1): 47-53. DOI: 10.1080/13556219872335.
|
[16] |
WAI CT, TAN BH, CHAN CL, et al. Drug-induced liver injury at an Asian center: A prospective study[J]. Liver Int, 2007, 27(4): 465-474. DOI: 10.1111/j.1478-3231.2007.01461.x.
|
[17] |
SARIN SK, CHOUDHURY A, SHARMA MK, et al. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific association for the study of the liver (APASL): An update[J]. Hepatol Int, 2019, 13(4): 353-390. DOI: 10.1007/s12072-019-09946-3.
|
[18] |
SARIN SK, KUMAR A, ALMEIDA JA, et al. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)[J]. Hepatol Int, 2009, 3(1): 269-282. DOI: 10.1007/s12072-008-9106-x.
|
[19] |
DEVARBHAVI H, CHOUDHURY AK, SHARMA MK, et al. Drug-induced acute-on-chronic liver failure in Asian patients[J]. Am J Gastroenterol, 2019, 114(6): 929-937. DOI: 10.14309/ajg.0000000000000201.
|
[20] |
HERNAEZ R, SOLÀ E, MOREAU R, et al. Acute-on-chronic liver failure: An update[J]. Gut, 2017, 66(3): 541-553. DOI: 10.1136/gutjnl-2016-312670.
|
[21] |
TESCHKE R, SCHULZE J, EICKHOFF A, et al. Drug induced liver injury: Can biomarkers assist RUCAM in causality assessment?[J]. Int J Mol Sci, 2017, 18(4): 803. DOI: 10.3390/ijms18040803.
|
[22] |
BENICHOU C, DANAN G, FLAHAULT A. Causality assessment of adverse reactions to drugs—Ⅱ. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge[J]. J Clin Epidemiol, 1993, 46(11): 1331-1336. DOI: 10.1016/0895-4356(93)90102-7.
|
[23] |
KLEINER DE, CHALASANI NP, LEE WM, et al. Hepatic histological findings in suspected drug-induced liver injury: Systematic evaluation and clinical associations[J]. Hepatology, 2014, 59(2): 661-670. DOI: 10.1002/hep.26709.
|
[24] |
KEAYS R, HARRISON PM, WENDON JA, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: A prospective controlled trial[J]. BMJ, 1991, 303(6809): 1026-1029. DOI: 10.1136/bmj.303.6809.1026.
|
[25] |
NABI T, NABI S, RAFIQ N, et al. Role of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: A prospective study[J]. Saudi J Gastroenterol, 2017, 23(3): 169-175. DOI: 10.4103/1319-3767.207711.
|
[26] |
HU J, ZHANG Q, REN X, et al. Efficacy and safety of acetylcysteine in "non-acetaminophen" acute liver failure: A meta-analysis of prospective clinical trials[J]. Clin Res Hepatol Gastroenterol, 2015, 39(5): 594-599. DOI: 10.1016/j.clinre.2015.01.003.
|
[27] |
RAKELA J, MOSLEY JW, EDWARDS VM, et al. A double-blinded, randomized trial of hydrocortisone in acute hepatic failure. The Acute Hepatic Failure Study Group[J]. Dig Dis Sci, 1991, 36(9): 1223-1228. DOI: 10.1007/BF01307513.
|
[28] |
MINDIKOGLU AL, MAGDER LS, REGEV A. Outcome of liver transplantation for drug-induced acute liver failure in the United States: Analysis of the United Network for Organ Sharing database[J]. Liver Transpl, 2009, 15(7): 719-729. DOI: 10.1002/lt.21692.
|
[29] |
CHOUDHARY NS, SAIGAL S, SARAF N, et al. Good outcome of living donor liver transplantation in drug-induced acute liver failure: A single-center experience[J]. Clin Transplant, 2017, 31(3): e12907. DOI: 10.1111/ctr.12907.
|
[30] |
LAI R, XIANG X, MO R, et al. Protective effect of Th22 cells and intrahepatic IL-22 in drug induced hepatocellular injury[J]. J Hepatol, 2015, 63(1): 148-155. DOI: 10.1016/j.jhep.2015.02.004.
|
[31] |
MCPHAIL MJ, FARNE H, SENVAR N, et al. Ability of King's College Criteria and Model for End-Stage Liver Disease scores to predict mortality of patients with acute liver failure: A Meta-analysis[J]. Clin Gastroenterol Hepatol, 2016, 14(4): 516-525. e5; quiz e43-e45. DOI: 10.1016/j.cgh.2015.10.007.
|
[32] |
KOCH DG, TILLMAN H, DURKALSKI V, et al. Development of a model to predict transplant-free survival of patients with acute liver failure[J]. Clin Gastroenterol Hepatol, 2016, 14(8): 1199-1206. e2. DOI: 10.1016/j.cgh.2016.03.046.
|
[33] |
ROBLES-DIAZ M, LUCENA MI, KAPLOWITZ N, et al. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury[J]. Gastroenterology, 2014, 147(1): 109-118. e5. DOI: 10.1053/j.gastro.2014.03.050.
|